Sehouli J - Search Results

1

[NF-kappaB subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression].

Niesporek S, Weichert W, Sinn B, Röske A, Noske A, Buckendahl AC, Wirtz R, Sehouli J, Koensgen D, Dietel M, Denkert C. Niesporek S, et al. Among authors: sehouli j. Verh Dtsch Ges Pathol. 2007;91:243-9. Verh Dtsch Ges Pathol. 2007. PMID: 18314621 German.

2

Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer.

Sehouli J, Mustea A, Koensgen D, Chen FC, Lichtenegger W. Sehouli J, et al. Ann Oncol. 2003 Oct;14(10):1501-4. doi: 10.1093/annonc/mdg413. Ann Oncol. 2003. PMID: 14504049 Free article.

3

Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.

Sehouli J, Mustea A, Koensgen D, Lichtenegger W. Sehouli J, et al. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1205-8. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652282

4

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.

Denkert C, Weichert W, Pest S, Koch I, Licht D, Köbel M, Reles A, Sehouli J, Dietel M, Hauptmann S. Denkert C, et al. Among authors: sehouli j. Cancer Res. 2004 Jan 1;64(1):189-95. doi: 10.1158/0008-5472.can-03-1987. Cancer Res. 2004. PMID: 14729623

5

Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.

Sehouli J, Drescher FS, Mustea A, Elling D, Friedmann W, Kühn W, Nehmzow M, Opri F, Klare P, Dietel M, Lichtenegger W. Sehouli J, et al. Anticancer Res. 2004 Mar-Apr;24(2C):1223-9. Anticancer Res. 2004. PMID: 15154651 Free article.

6

[Conventional and experimental prognostic factors in ovarian cancer].

Sehouli J, Mustea A, Könsgen D, Lichtenegger W. Sehouli J, et al. Zentralbl Gynakol. 2004 Oct;126(5):315-22. doi: 10.1055/s-2004-832305. Zentralbl Gynakol. 2004. PMID: 15478050 Review. German.

7

Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells.

Sun P, Sehouli J, Denkert C, Mustea A, Könsgen D, Koch I, Wei L, Lichtenegger W. Sun P, et al. Among authors: sehouli j. J Mol Med (Berl). 2005 Jun;83(6):457-67. doi: 10.1007/s00109-005-0639-3. Epub 2005 Mar 16. J Mol Med (Berl). 2005. PMID: 15770498

8

Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis.

Niesporek S, Denkert C, Weichert W, Köbel M, Noske A, Sehouli J, Singer JW, Dietel M, Hauptmann S. Niesporek S, et al. Among authors: sehouli j. Br J Cancer. 2005 May 9;92(9):1729-36. doi: 10.1038/sj.bjc.6602528. Br J Cancer. 2005. PMID: 15841084 Free PMC article.

9

[Role of estrogen receptor-related receptors alpha, beta and gamma in ovarian cancer cells].

Sun PM, Wei LH, Sehouli J, Denkert C, Zhao D, Gao M, Sun XL, Litchtenegger W. Sun PM, et al. Among authors: sehouli j. Zhonghua Fu Chan Ke Za Zhi. 2005 Aug;40(8):544-8. Zhonghua Fu Chan Ke Za Zhi. 2005. PMID: 16202294 Chinese.

10

Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.

Noske A, Kaszubiak A, Weichert W, Sers C, Niesporek S, Koch I, Schaefer B, Sehouli J, Dietel M, Lage H, Denkert C. Noske A, et al. Among authors: sehouli j. Cancer Lett. 2007 Feb 8;246(1-2):190-200. doi: 10.1016/j.canlet.2006.02.018. Epub 2006 Apr 3. Cancer Lett. 2007. PMID: 16584837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters